1
Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients
Condition(s):Opioid Use, Unspecified With Other Opioid-induced DisorderLast Updated:October 26, 2016Completed
Methylnaltrexone as an Intervention: 58 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
Condition(s):Neoplasms; Constipation; Opioid-Related DisordersLast Updated:February 2, 2016Completed
3
A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer
Condition(s):Pancreatic CancerLast Updated:May 7, 2021Withdrawn
4
An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer
Condition(s):Pancreatic CancerLast Updated:May 7, 2021Withdrawn
5
Methylnaltrexone for Opioid Induced Constipation
Condition(s):ConstipationLast Updated:August 5, 2019Terminated
6
Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness
Condition(s):Opioid-Induced ConstipationLast Updated:March 7, 2018Completed
7
Compassionate Use Study of Methylnaltrexone
Condition(s):Opioid-induced ConstipationLast Updated:September 4, 2019Completed
8
Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation
Condition(s):Constipation Drug InducedLast Updated:March 25, 2022Recruiting
9
A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain
Condition(s):Opioid-Induced ConstipationLast Updated:September 6, 2019Completed
10
Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit
Condition(s):Opioid-induced ConstipationLast Updated:January 15, 2010Unknown status